Annual CFF
$164.00 M
-$1.90 M-1.15%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual cash flow from financing activities is $164.00 million, with the most recent change of -$1.90 million (-1.15%) on December 31, 2023.
- During the last 3 years, DAWN annual CFF has risen by +$134.02 million (+447.08%).
- DAWN annual CFF is now -44.80% below its all-time high of $297.12 million, reached on December 31, 2021.
Performance
DAWN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$200.09 M
+$198.80 M+15327.53%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly cash flow from financing activities is $200.09 million, with the most recent change of +$198.80 million (+15327.53%) on September 30, 2024.
- Over the past year, DAWN quarterly CFF has increased by +$199.50 million (+33416.75%).
- DAWN quarterly CFF is now at all-time high.
Performance
DAWN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$202.04 M
+$199.98 M+9721.93%
September 30, 2024
Summary
- As of February 7, 2025, DAWN TTM cash flow from financing activities is $202.04 million, with the most recent change of +$199.98 million (+9721.93%) on September 30, 2024.
- Over the past year, DAWN TTM CFF has increased by +$38.04 million (+23.20%).
- DAWN TTM CFF is now -38.29% below its all-time high of $327.39 million, reached on June 30, 2021.
Performance
DAWN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DAWN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.1% | +10000.0% | +23.2% |
| 3 y3 years | +447.1% | +9646.5% | +23.0% |
| 5 y5 years | +430.6% | +9646.5% | +23.0% |
DAWN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.8% | at low | at high | -100.0% | -32.0% | +9721.9% |
| 5 y | 5-year | -44.8% | +447.1% | at high | >+9999.0% | -38.3% | -100.0% |
| alltime | all time | -44.8% | +447.1% | at high | >+9999.0% | -38.3% | -100.0% |
Day One Biopharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $200.09 M(>+9900.0%) | $202.04 M(+9721.9%) |
| Jun 2024 | - | $1.30 M(+2602.1%) | $2.06 M(-98.7%) |
| Mar 2024 | - | $48.00 K(-92.0%) | $162.86 M(-0.7%) |
| Dec 2023 | $164.00 M(-1.1%) | $597.00 K(+419.1%) | $164.00 M(-0.8%) |
| Sep 2023 | - | $115.00 K(-99.9%) | $165.32 M(-1.2%) |
| Jun 2023 | - | $162.10 M(>+9900.0%) | $167.26 M(+0.1%) |
| Mar 2023 | - | $1.18 M(-38.3%) | $167.09 M(+0.7%) |
| Dec 2022 | $165.90 M | $1.92 M(-6.6%) | $165.90 M(+1.0%) |
| Sep 2022 | - | $2.05 M(-98.7%) | $164.30 M(+1.7%) |
| Jun 2022 | - | $161.93 M(>+9900.0%) | $161.63 M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | $168.24 M(-43.4%) |
| Dec 2021 | $297.12 M(+891.2%) | $318.00 K(-151.7%) | $297.12 M(-9.1%) |
| Sep 2021 | - | -$615.00 K(-100.4%) | $326.78 M(-0.2%) |
| Jun 2021 | - | $168.53 M(+30.8%) | $327.39 M(+106.1%) |
| Mar 2021 | - | $128.88 M(+329.9%) | $158.86 M(+429.9%) |
| Dec 2020 | $29.98 M(-3.0%) | $29.98 M(>+9900.0%) | $29.98 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $30.91 M | - | - |
FAQ
- What is Day One Biopharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual CFF year-on-year change?
- What is Day One Biopharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly CFF year-on-year change?
- What is Day One Biopharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM CFF year-on-year change?
What is Day One Biopharmaceuticals annual cash flow from financing activities?
The current annual CFF of DAWN is $164.00 M
What is the all time high annual CFF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual cash flow from financing activities is $297.12 M
What is Day One Biopharmaceuticals annual CFF year-on-year change?
Over the past year, DAWN annual cash flow from financing activities has changed by -$1.90 M (-1.15%)
What is Day One Biopharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of DAWN is $200.09 M
What is the all time high quarterly CFF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly cash flow from financing activities is $200.09 M
What is Day One Biopharmaceuticals quarterly CFF year-on-year change?
Over the past year, DAWN quarterly cash flow from financing activities has changed by +$199.50 M (+33416.75%)
What is Day One Biopharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of DAWN is $202.04 M
What is the all time high TTM CFF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM cash flow from financing activities is $327.39 M
What is Day One Biopharmaceuticals TTM CFF year-on-year change?
Over the past year, DAWN TTM cash flow from financing activities has changed by +$38.04 M (+23.20%)